Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIA-cN2”

3 trials

Showing 3 of 3 results

Not applicableLooking for participantsNCT04677205
What this trial is testing

Molecular Signature From Tumor to Lymph Nodes

Who this might be right for
Lung CancerStage IIIA-cN2Operated With Curative Intent+2 more
Assistance Publique - Hôpitaux de Paris 200
Testing effectiveness (Phase 2)Ended earlyNCT00271323
What this trial is testing

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Who this might be right for
Non-Small-Cell Lung Carcinoma
Sanofi 14
Testing effectiveness (Phase 2)Study completedNCT00174772
What this trial is testing

Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Neoplasms
Sanofi 72

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation